Terms: = Leukemia AND BCL2, Bcl-2, 596, ENSG00000171791 AND Staging
24 results:
1. Chronic lymphocytic leukemia: 2022 update on diagnostic and therapeutic procedures.
Hallek M; Al-Sawaf O
Am J Hematol; 2021 Dec; 96(12):1679-1705. PubMed ID: 34625994
[TBL] [Abstract] [Full Text] [Related]
2. RPPA-based proteomics recognizes distinct epigenetic signatures in chronic lymphocytic leukemia with clinical consequences.
van Dijk AD; Griffen TL; Qiu YH; Hoff FW; Toro E; Ruiz K; Ruvolo PP; Lillard JW; de Bont ESJM; Burger JA; Wierda W; Kornblau SM
Leukemia; 2022 Mar; 36(3):712-722. PubMed ID: 34625713
[TBL] [Abstract] [Full Text] [Related]
3. Venetoclax in relapsed/refractory blastic plasmacytoid dendritic cell neoplasm with central nervous system involvement: a case report and review of the literature.
Albiol N; Novelli S; Mozos A; Pratcorona M; Martino R; Sierra J
J Med Case Rep; 2021 Jun; 15(1):326. PubMed ID: 34172079
[TBL] [Abstract] [Full Text] [Related]
4. Excessive amount and activity of μ-calpain affects apoptotic machinery in chronic B-cell leukemia cells and influences the course of the disease.
Łopatniuk P; Puchalska Z; Mital A; Mikosik A; Frąckowiak J; Hellmann A; Daca A; Bryl E; Fulop T; Witkowski JM
Acta Biochim Pol; 2020 Jun; 67(2):247-257. PubMed ID: 32544313
[TBL] [Abstract] [Full Text] [Related]
5. PET-adapted treatment for newly diagnosed advanced Hodgkin lymphoma (AHL2011): a randomised, multicentre, non-inferiority, phase 3 study.
Casasnovas RO; Bouabdallah R; Brice P; Lazarovici J; Ghesquieres H; Stamatoullas A; Dupuis J; Gac AC; Gastinne T; Joly B; Bouabdallah K; Nicolas-Virelizier E; Feugier P; Morschhauser F; Delarue R; Farhat H; Quittet P; Berriolo-Riedinger A; Tempescul A; Edeline V; Maisonneuve H; Fornecker LM; Lamy T; Delmer A; Dartigues P; Martin L; André M; Mounier N; Traverse-Glehen A; Meignan M
Lancet Oncol; 2019 Feb; 20(2):202-215. PubMed ID: 30658935
[TBL] [Abstract] [Full Text] [Related]
6. Chronic lymphocytic leukaemia.
Hallek M; Shanafelt TD; Eichhorst B
Lancet; 2018 Apr; 391(10129):1524-1537. PubMed ID: 29477250
[TBL] [Abstract] [Full Text] [Related]
7. NFATC1 activation by DNA hypomethylation in chronic lymphocytic leukemia correlates with clinical staging and can be inhibited by ibrutinib.
Wolf C; Garding A; Filarsky K; Bahlo J; Robrecht S; Becker N; Zucknick M; Rouhi A; Weigel A; Claus R; Weichenhan D; Eichhorst B; Fischer K; Hallek M; Kuchenbauer F; Plass C; Döhner H; Stilgenbauer S; Lichter P; Mertens D
Int J Cancer; 2018 Jan; 142(2):322-333. PubMed ID: 28921505
[TBL] [Abstract] [Full Text] [Related]
8. Evaluation of MiR-15a and MiR-16-1 as prognostic biomarkers in chronic lymphocytic leukemia.
Braga TV; Evangelista FCG; Gomes LC; Araújo SSDS; Carvalho MDG; Sabino AP
Biomed Pharmacother; 2017 Aug; 92():864-869. PubMed ID: 28599250
[TBL] [Abstract] [Full Text] [Related]
9. [Analysis of Indicators Related with Cell Proliferation and Apoptosis in the Patients with B Cell Non-Hodgkin's Lymphoma].
Yin JJ; Liang B; Lu Y; Zhan XR
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Dec; 24(6):1771-1775. PubMed ID: 28024492
[TBL] [Abstract] [Full Text] [Related]
10. An international prognostic index for patients with chronic lymphocytic leukaemia (CLL-IPI): a meta-analysis of individual patient data.
International CLL-IPI working group
Lancet Oncol; 2016 Jun; 17(6):779-790. PubMed ID: 27185642
[TBL] [Abstract] [Full Text] [Related]
11. Chronic lymphocytic leukemia (CLL)-Then and now.
Rai KR; Jain P
Am J Hematol; 2016 Mar; 91(3):330-40. PubMed ID: 26690614
[TBL] [Abstract] [Full Text] [Related]
12. The downregulation of Mcl-1 via USP9X inhibition sensitizes solid tumors to Bcl-xl inhibition.
Peddaboina C; Jupiter D; Fletcher S; Yap JL; Rai A; Tobin RP; Jiang W; Rascoe P; Rogers MK; Smythe WR; Cao X
BMC Cancer; 2012 Nov; 12():541. PubMed ID: 23171055
[TBL] [Abstract] [Full Text] [Related]
13. Correlation between tumor-associated proteins and response to neoadjuvant treatment in patients with advanced squamous-cell esophageal cancer.
Farkas R; Pozsgai E; Bellyei S; Cseke L; Szigeti A; Vereczkei A; Marton S; Mangel L; Horvath OP; Papp A
Anticancer Res; 2011 May; 31(5):1769-75. PubMed ID: 21617238
[TBL] [Abstract] [Full Text] [Related]
14. [Expression and significance of B cell-activating factor of TNF family (BAFF) and B cell lymphoma/leukemia-2 (bcl-2) in multiple myeloma].
Wang SM; Zhang TL; Jiang YM; Wu HY; Hao LM; Xing XH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Apr; 19(2):395-8. PubMed ID: 21518495
[TBL] [Abstract] [Full Text] [Related]
15. Chronic lymphocytic leukemia: insights from lymph nodes & bone marrow and clinical perspectives.
Jaksić O; Kardum-Skelin I; Jaksić B
Coll Antropol; 2010 Mar; 34(1):309-13. PubMed ID: 20432765
[TBL] [Abstract] [Full Text] [Related]
16. Subclinical chronic lymphocytic leukemia with atypical cutaneous presentation.
Ali L; Cheney R; Merzianu M
J Cutan Pathol; 2011 Feb; 38(2):236-40. PubMed ID: 19719832
[TBL] [Abstract] [Full Text] [Related]
17. CD40 ligand, bcl-2 and apoptosis in B-chronic lymphocytic leukemia.
Hussein OA; Omran AA; Elnaggar AM; Fathy A
Egypt J Immunol; 2009; 16(2):27-36. PubMed ID: 22059351
[TBL] [Abstract] [Full Text] [Related]
18. Fludarabine induces apoptosis in chronic lymphocytic leukemia--the role of P53, bcl-2, Bax, Mcl-1, and Bag-1 proteins.
Faria JR; Yamamoto M; Faria RM; Kerbauy J; Oliveira JS
Braz J Med Biol Res; 2006 Mar; 39(3):327-33. PubMed ID: 16501812
[TBL] [Abstract] [Full Text] [Related]
19. Sequential application of chemotherapy and monoclonal CD 20 antibody: successful treatment of advanced composite-lymphoma.
Linck D; Lentini G; Tiemann M; Fauser AA; Parwaresch R; Basara N
Leuk Lymphoma; 2005 Feb; 46(2):285-8. PubMed ID: 15621815
[TBL] [Abstract] [Full Text] [Related]
20. Clinical significance of CD38 expression in chronic lymphocytic leukemia.
Del Poeta G; Maurillo L; Venditti A; Buccisano F; Epiceno AM; Capelli G; Tamburini A; Suppo G; Battaglia A; Del Principe MI; Del Moro B; Masi M; Amadori S
Blood; 2001 Nov; 98(9):2633-9. PubMed ID: 11675331
[TBL] [Abstract] [Full Text] [Related]
[Next]
